Five Star Friday: Vox, WSJ, NPR, USA Today, NY Times earn kudos

Five Star Friday: Vox, WSJ, NPR, USA Today, NY Times earn kudos

The Effects of Stress on Your Body and Mind Are Staggering! Watch The Video Below To See What You Can Do To Regain Your Health...

Discover How Laminine™ Can Improve Your Health... Watch The Video Above!

Laminine™ Will Help Anyone. The Benefits, When Taken Regularly May Include...

  • Moderate the Stress Response
  • Maintain Healthy Cortisol Levels
  • Regulate Serotonin Levels
  • Reduce Physical and Mental Stress
  • Help Your Body Recover from Major Illnesses (e.g. Depression, Anxiety, Cancer)
  • Promote More Restful Sleep
  • Build Collagen for Healthier Skin
  • Reduce Signs of Normal Aging
  • Improve Emotional Balance
  • Promote Faster Post Workout Recovery
And Many More Health Benefits Reported By Everyday Users!




  • Enhance Muscle Tone and Strength
  • Improve Stamina and Energy
  • Increase Alertness
  • Aid in Brain Function and Activity (For people suffering from Alzheimer's syndrome, ADD, etc.)
  • Increase Physical and Mental Strength
  • Improve Focus
  • Increase Libido/Sexual Desire
  • Stimulate Natural DHEA Production
  • Improve the Overall Sense of Well-Being

Make 2017... the Year You Improve Your Health!

Join Thousands in 42 Countries (shown at the bottom of this page) Who Are Already Seeing Amazing Health Benefits from Regular Use of Laminine™ & Laminine™ Omega Plus!

"The Happy Pill"

Laminine™ is a Natural, Synergistic SuperFood that contains 22 amino acids, trace minerals, vitamins and Fibroblast Growth Factor (FGF) The perfect combination of life-giving sustenance sourced from land, sea and plant. Its source is from the "Miracle of Life". 

 Clinical Studies have been conducted which showed Laminine's™ positive effects on Physical, Mental, Emotional Strengths and Overall Health. Laminine™ is an all Natural Product
CLICK HERE To Join My Group & Order (Wholesale) & Choose the "Laminine™ Activation Pack"

Blue 5-star heroIt’s been a while since we’ve shined a light on important work in health care journalism, including these two stories that earned a top 5-star rating from our reviewers.

We recognize that some of the best work being done in health care journalism often falls outside our limited number of systematic story reviews.  But here are some recent gems:

  • Tara Haelle’s piece that appeared on, “Study says Flumist vaccine does indeed work, contradicting CDC.”  Excerpt: “But things aren’t so simple. In fact, the conflicting evidence about the live nasal flu vaccine offers an excellent case study on how complex the task of analyzing flu vaccine data and making recommendations really is.”
  • Liz Szabo’s story for USA Today, “New cholesterol drugs could add $120 billion to annual US health costs.” Excerpt: “Authors of the analysis said they hope the estimate will spur a national conversation about drug prices, the value of new medications and how much Americans are willing to pay to improve health.”

We also appreciate the New York Times “Ask Well” explainer: Is dementia the same as Alzheimer’s disease?  And we’d like to call attention to their recent series on cancer immunotherapy called Cell Wars. These in-depth stories explore the promise of several new cancer immunotherapy approaches as well as their downsides — balancing optimism with the cold reality that these drugs carry risks and still don’t work for the vast majority of patients. Denise Grady, Andrew Pollack, and Matt Richtel have all contributed to the series. We commend the Times for publishing critical reader reactions to the stories, several of which stress concerns that we’ve also raised about coverage of these new therapies.

Excerpt from a letter by oncologist Steven Sorscher:

…as patients contemplate their limited options, it is important that journalists present the promise of these drugs in a more balanced manner, just as industry and oncologists must do.

For example, nivolumab was one of the immunotherapy drugs highlighted in your article. The most common cancer for which it is approved by the Food and Drug Administration is lung cancer, which is also by far the most common cause of cancer death in this country. You reported on the remarkable results seen in three patients with lung cancer who received immunotherapy, and none who fared otherwise.

Excerpt from a letter by Dr. Deborah Doroshow:

Some of my patients have remarkable responses, living years when they might have previously lived months.

But I also play the role of doctor on call, admitting patients with life-threatening lung or colon inflammation that can result from these drugs. Furthermore, the vast majority of my patients don’t respond to these drugs at all.

It is critical that we continue to learn why some patients respond to these medications while others do not. But it is just as important that we not give our patients false hope while embracing the potential of a new approach to treating cancer.

The post Five Star Friday: Vox, WSJ, NPR, USA Today, NY Times earn kudos appeared first on

After Clicking on One of the Links Below, Just CLICK the "Click Here to Agree and Continue" Button in the "Informed Consent and Participation Agreement" Form... to Begin Your Own Personal Q & A Session on How Laminine and Laminine Omega +++ Can Help You Achieve PERFECT Health.

Updated: August 21, 2016 — 3:00 am

Copyright © 2019 - All Rights Reserved - Site Map - Resources (Add Your Link)

The statements and products referred to throughout this site have not been evaluated by the FDA. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult a physician.

Glenn Freiboth - (815) 524-3752 - CST - [email protected] - Company Site
An Independent Lifepharm® Distributor

Available In The Countries Below: 

Australia, Austria, Belgium, Bosnia-Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Indonesia, Ireland, Italy, Jamaica, Japan, Kazakhstan, Latvia, Lithuania, Luxembourg, Macedonia, Malaysia, Malta, Netherlands, New Zealand, Philippines, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Ukraine, United Kingdom, United States - More Countries Coming Soon!